EU pharma manufacturers to benefit from new Bosnia trade deal
EU ministers have been asked to approve swiftly a comprehensive trade agreement between the EU and Bosnia & Herzegovina, slashing duties on EU exports of pharmaceutical inputs.
EU ministers have been asked to approve swiftly a comprehensive trade agreement between the EU and Bosnia & Herzegovina, slashing duties on EU exports of pharmaceutical inputs.
The move follows approval of long awaited Bosnian policing reforms, which were a condition of the deal.
As soon as the deal is formally approved by the EU Council of Ministers and the Bosnian federal parliament, Bosnian import duties on EU-made products or preparations used to make pharmaceuticals; certain intermediate products used to make antibiotics; and gelatin capsules used to make drugs, would be halved and scrapped altogether the following January.